Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
Public ClinicalTrials.gov record NCT01655849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy and Safety of Z160 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare Z160 and placebo in patients with Lumbosacral Radiculopathy for safety and efficacy for a period of 6 weeks.
Study identification
- NCT ID
- NCT01655849
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 141 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2012 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Nov 2013 (Actual)
- Last update posted
- Dec 12, 2013
2012 – 2013
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Huntsville | Alabama | 35801 | — |
| Investigative Site | Peoria | Arizona | 85381 | — |
| Investigative Site | Anaheim | California | 92804 | — |
| Investigative Site | Fresno | California | 93726 | — |
| Investigative Site | Orange | California | 92868 | — |
| Investigative Site | Sacramento | California | 95821 | — |
| Investigative Site | Clearwater | Florida | 33756 | — |
| Investigative Site | Clearwater | Florida | 33765 | — |
| Investigative Site | Orlando | Florida | 32806 | — |
| Investigative Site | Pinellas Park | Florida | 33781 | — |
| Investigative Site | Plantation | Florida | 33317 | — |
| Investigative Site | Royal Palm Beach | Florida | 33411 | — |
| Investigative Site | Atlanta | Georgia | 30342 | — |
| Investigative Site | Overland Park | Kansas | 66210 | — |
| Investigative Site | Shreveport | Louisiana | 71105 | — |
| Investigative Site | Boston | Massachusetts | 02135 | — |
| Investigative Site | Hazelwood | Missouri | 63042 | — |
| Investigative Site | Las Vegas | Nevada | 89144 | — |
| Investigative Site | Medford | Oregon | 97504 | — |
| Investigative Site | Duncansville | Pennsylvania | 16635 | — |
| Investigative Site | Dallas | Texas | 75230 | — |
| Investigative Site | Sandy City | Utah | 84070 | — |
| Investigative Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01655849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2013 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01655849 live on ClinicalTrials.gov.